Andrew Renehan is Professor of Cancer Studies and Surgery and leads the Manchester Cancer Research Centre (MCRC) Diabesity and Cancer Research Group, studying relationships between obesity, diabetes, and anti-diabetes therapies, with cancer risk and outcomes - including clinical epidemiology and translational studies. This group is located within the Cancer Screening and Prevention hub at the MCRC Kinnaird Road site and at the Farr Institute@HeRC at Vaughan House on the main University campus. At any one time, he has a team of 1 to 2 postgraduate fellows and 3 to 4 students working on projects in this theme. He is a founder co-chair of the Cancer Prevention Research Network; the bio-statistical lead for biomarker development in the Clinical and Experimental Pharmacology Group, CR UK Manchester Institute; current chair of the European Association for the Study of Diabetes (EASD) Diabetes and Cancer Study Group; co-chair of the MCRC clinical training fellowships scheme. He was one of 21 international scientists in the IARC handbook writing group on obesity and cancer in 2016.
He is honorary consultant colorectal surgeon at the Christie NHS Foundation Trust; leads on clinical research in that group and leads the Christie Surgical Oncology Research theme. He is a core member of the Manchester Peritoneal Tumour Service - one of two nationally commissioned treatment centres for peritoneal surface malignancies. His work is divided 50:50 between research and clinical service in a bi-weekly timetable.
Professor Renehan holds honours degrees in Dentistry from Trinity College Dublin (1986) and Medicine from the University of Manchester (1995) - gold medal for surgical finals.
Professor Renehan holds honours degrees in Dentistry from Trinity College, Dublin (1986) and Medicine from the University of Manchester - gold medal for surgical finals. He undertook his PhD thesis on the role of IGFs in cancer in the laboratories of Professor Chris Potten, Paterson Institute for Cancer Research; Miss Sarah T O'Dwyer, Colorectal Surgery, The Christie; Professor Steve Shalet, Endocrinology, The Christie.
He was appointed a "new blood" senior lecturer in the School of Cancer Sciences and Honorary Consultant Colorectal Surgeon at the Christie NHS Foundation Trust, Manchester in 2007 and promoted to Professor of Cancer Studies and Surgery in 2013 within the Institute of Cancer Sciences.
He held the British Travelling Fellowship (for Coloproctology) in 2009 and was the Royal College of Surgeons of England Hunterian Professor in 2011.